Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LL…
Official notice from a government agency or its published feed.
Reason: Lack of assurance of sterility.
Class IIA mid-level FDA recall: the product may cause temporary or reversible health problems. · Ongoing · Nationwide in the USA.
Hazard: Lack of assurance of sterility.
View the FDA enforcement report ↗ ← All reports